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Between May 2007 and April 2009, 29 falcons with identically localized, yellowish discolored cutaneous lesions in the thigh and
lateral body wall region were presented at Abu Dhabi Falcon Hospital. Out of 18 falcons integrated in this study, 16 tested positive
to Mycobacterium. avium complex. The 2 negative falcons tested positive in the Mycobacterium genus PCR. Moreover, 1 falcon
tested positive to M. avium. paratuberculosis in tissue samples by PCR. In all cases, blood and fecal samples tested negative. In
the acid-fast stain, all samples showed the for mycobacteriosis typical rods. Moreover, in 13 samples Acinetobacter baumannii was
detectedbyPCRandprovenbyDNAsequencing.ClinicalfeaturesincludedhighlyelevatedWBCs,heterophilia,lymphocytopenia,
monocytosis, severe anemia and weight loss. A. baumannii, a gram-negative bacillus with the ability to integrate foreign DNA, has
emerged as one of the major multidrug resistant bacteria. In veterinary medicine, it has so far been detected in dogs, cats, horses
and wild birds. To the authors’ knowledge, this is the ﬁrst report of an A. baumannii infection in falcons and of a veterinary
Mycobacterium-Acinetobacter coinfection.
1.Introduction
The genus Acinetobacter comprises strictly aerobic, gram-
negative and nonfermentative bacteria belonging to the
family Moxarellaceae. They are widely distributed in the
environment as well as in hospitals, where they can survive
on moist or dry surfaces for long periods of time [1]o n
dry surfaces [2]. Acinetobacter can also be found in soil and
constitutesasoneofthepredominantorganismsinwater[3].
A. baumannii is the most commonly found Acinetobacter
species in humans and has emerged as multidrug resistant
[1]. Moreover, it has evolved as one of the most important
nosocomial pathogens in the past decade [4] particularly
in immunosuppressed patients [1]. A. baumannii can aﬀect
diﬀerent organs causing pneumonia, meningitis, septicemia
and urinary tract [5] and skin infections [4]. However, it
is still not entirely clear how A. baumannii is transmitted.
Its “success” as an emerging pathogen might be based on
its ability to integrate large amounts of foreign DNA into
its genome, located as signiﬁcant fractions of ORFs on 28
putative alien islands [5] .R i s kf a c t o r ss u c ha su n d e r l y i n g
diseases or infections of the aﬀected patient, hospitalization,
cephalosporin treatment, and medical procedures may pave
the way for A. baumannii infections [4]. Antimicrobial
treatment can be considered as a predisposing factor for
A. baumannii infections [4]. Between January 2002 and
August 2004, A. baumannii infections were diagnosed when
“military health oﬃcials identiﬁed 102 patients with blood
cultures that grew A. baumannii at military medical facilities
treating service members injured in Afghanistan and the
Iraq/Kuwaitregion”(CDC,2004).Apotentialenvironmental
contamination of traumatic injuries might have been an
inﬂuencing factor (CDC, 2004). Moreover, A. baumannii is
known to survive for long periods of time.
IncontrasttoA.baumanniiinfections,mycobacteriosisis
well described in birds and mainly caused by Mycobacterium
avium and Mycobacterium genavense. Both pathogens are
excreted with the feces [6, 7]a n da ﬀect mainly hepatic and2 Veterinary Medicine International
gastrointestinal organ systems [8]. Water, soil, plants and
other environmental sources serve as reservoirs for the M.
avium complex [9]. M. avium can be transmitted from birds
to immunosuppressed humans like AIDS patients [9]a n d
has been isolated from cutaneous tuberculosis lesions in
humans [10].
General symptoms of mycobacteriosis include weight
loss, polyuria, coelomic distention, and diarrhea. Rarely
cutaneous masses and lameness can be found [7]. Skin
granulomas caused mainly by M. genavense can be ﬂaky,
dry, or raised ulcers and are usually not painful [11].
GranulomatousdermatitisinpsittacinescanbecausedbyM.
genavense,t o o[ 12].
2.MaterialandMethods
2.1. Clinical Investigation. From May 2007 to April 2009, a
total number of 29 falcons, among them 19 Gyr-Peregrine
hybrid falcons, 9 Gyr-Saker hybrid falcons, and 1 peregrine
falcon, were presented at the Abu Dhabi Falcon Hospital. 26
falcons were females and 2 Gyr-Peregrine hybrid falcons and
1 Gyr-Saker hybrid falcons were males. All falcons belonged
to diﬀerent owners and were bred by diﬀerent breeders in
UAE and Europe. The falcons’ age was between 1 and 3 years
and all were used for hunting.
For this study, a group of 18 falcons was selected for
which all below-mentioned tests could be performed. For
the other 11 falcons, most of the tests were performed
but not all tests could be done. Therefore, those falcons
were excluded from the study. Out of the 18 falcons, 16
falcons had repeatedly visited the hospital. For 2 falcons,
it was the ﬁrst visit. In most falcons, a time span of
at least 3-5 months between being diagnosed without
abnormality and the manifestation of visible lesions could
be observed. One falcon from the UK came from a breeding
center where previously another falcon had been diagnosed
with mycobacteriosis granuloma. All 18 falcons were either
diagnosed with unspeciﬁc symptoms, including anorexia,
weight loss, and not ﬂying well or presented only for general
examination. However, all falcons had cutaneous yellowish-
colored lesions. Those lesions were located on the right and
left lower thoracical body wall and abdominal body walls as
well as the inside of both thighs. The lesions were opened
surgically and tissue material was extracted for examination.
Then the lesions were sutured with 3–0 Ethilon∗ (Ethicon,
Johnson and Johnson, Belgium).
2.2. Laboratory Diagnostics
2.2.1. Blood Examination. Blood samples for hematological
and biochemical examination were taken from the left or
right V. cutanea ulnaris superﬁcialis and processed within
maximum 30 minutes in the laboratory. The blood hema-
tology was performed according to the protocol of Muller
et al. [13]. The ACE-Wasserman biochemistry analyser
(Schiaparelli Biosystems) was used to measure the blood
chemistry parameters by photometry. In 10 falcons, blood
was taken 1–3 times. In 8 falcons, the blood sampling
w a sr e p e a t e d3u pt o8t i m e se v e r y3t o8d a y s .T h e
blood sampling of one Gyr-peregrine hybrid falcon was not
possible due to poor condition of the bird.
2.2.2. Acid-Fast Bacilli Staining. Acid-fast bacilli staining
withZiehl-Neelsen(ZN)stain(ZN-TBStainKit(AFBStain),
GCC Diagnostics, Flintshire, UK) was performed for the
biopsied tissues and fecal samples of all falcons tested.
2.2.3. Molecular Analysis. The tissues as well as blood and
fecal samples were examined by PCR. DNA was extracted
from fresh tissue and one blood sample using DNA-Sorb-
A DNA Extraction Kit (Sacace Biotechnologies Srl, Caserta,
Italy) as per the manufacturers’ instruction followed by
ampliﬁcation of the Mycobacterium genus DNA using the
Mycobacterium genus PCR Kit including 4 diﬀerent primer
pairs for M. genus, M. tuberculosis, M. avium paratubercu-
losis, and M. avium avium (Genekam Biotechnology, AG,
Germany). The PCR was performed in a ﬁnal volume of
20µL. The reaction mixture was then subjected to 38 cycles
of ampliﬁcation. (Denaturation at 94
◦C for 30 seconds,
annealing at 65
◦C for 60 seconds, and extension at 72
◦Cf o r
120 seconds). After PCR ampliﬁcation, a 10µL aliquot of the
PCR products was electrophoresed for 1 hour through a 2%
agarose gel. The target band of 236bp (of Mycobacterium
genus DNA) was visualized under UV illumination.
In order to clarify why the Mycobacterium-speciﬁc
PCR was negative in most samples despite a clinically
suspected mycobacteriosis and to identify the mycobacterial
species, a seminested PCR designed for diagnosis of avian
mycobacteriosis [14] was performed with all samples. In
brief, for the ﬁrst round primers 246 and 247 were used
to amplify an approximately 600bp, and the amplicon was
then subjected to a second round using the p7 and the
247 primers and resulting in a ∼550bp fragment of the
ﬁrst amplicon. Ampliﬁcation of the respective fragments
was visualized by ethidium-bromide in a 2% agarose gel
electrophoresis. For identiﬁcation, the resulting amplicons
were subjected to DNA sequencing. Sequencing was carried
out in a 310 ABI PRISM automated sequencer (Applied
Biosystems, Langen, Germany) and sequences were com-
pared to sequences available at GenBank using BLAST search
[15]. Moreover, samples (except samples 3 and 10, from
which no material was left) were screened with a universal
bacterial PCR using the 16S for and 16S rev primers [16]
and as sequencing of the respective amplicons revealed
highest identity of the sequences to Acinetobacter baumannii,
all positive samples were screened with a PCR speciﬁc for A.
baumannii [17] amplifying the internal transcribed spacer
(ITS) region. Again, ampliﬁcation was visualized by 2%
agarose gelelectrophoresis and amplicons were excised from
the gels and subjected to DNA sequencing.
3. Results
3.1. Clinical Inspection. Out of 18 falcons, a total number
of 26 cutaneous lesions were found. 94% of the falcons had
a lesion on the left and/or right body wall, whereas 50%Veterinary Medicine International 3
Table 1: Location and diameter of cutaneous lesions.
S. No Lesion on left lower thoracical
and abdominal wall
Lesion on right lower thoracical
and abdominal wall
Lesion on medial part of
left thigh
Lesion on medial
part of right thigh
1 0.5–1cm 0.5–1cm
2 2.1–5cm
3 0.5–1cm 0.5–1cm 1.1–2cm 1.1–2cm
4 1.1–2cm













18 larger than 5cm
showed lesions on either or both thigh inside areas (Table 1).
Except for two falcons treated, all other falcons died or were
euthanized as per request of their owners.
In 39% of the falcons, no other microorganisms were
detected. In the remaining 61%, more than one infection
was found. Among these, 37% of falcons were identiﬁed
with aspergillosis. 6% showed hepatopathic lesions and in
18%, hepatomegaly was detected. Moreover, 6% suﬀered
from pseudomoniasis. Airsacculitis was detected in 6% and
infestation with Serratospiculum seurati worms in another
6% of falcons.
3.2. Blood Examination. T h eb l o o de x a m i n a t i o n sw e r es e p -
arated according to the hybrid species. Moreover, the mean
values for hematology and blood biochemistry of all falcons
inthestudywereestablished.Furthermore,thebloodparam-
eters’ mean values of falcons with mycobacteriosis combined
withA. baumannii infection were evaluated (Tables 2 and 3).
The established values were compared to reference values for
hematology [13, 18] and biochemistry [18].
3.3. Ziehl-Neelsen Staining. In the Ziehl-Neelsen (ZN) stain,
acid-fast bacilli were detected in the cytological squash
of biopsied cutaneous tissues as well as fecal material of
all falcons tested. In 50 %, the stain revealed acid-fast
bacilli covering 2/3 or more of each examined microscopic
ﬁeld (Figure 1). In the remaining cases, 1/3 to 2/3 of the
microscopic slides were covered with acid-fast bacilli in the
Figure 1: Acid fast organisms stain in bright pink color.
ZN stain. Only in 11%, acid-fast bacilli were additionally
identiﬁed in the feces material.
3.4. Molecular Results. Molecular results are summarised in
Table 4. In the Mycobacterium genus PCR, all samples except
samples 8, 9, 10, and 11 were positive. The Mycobacterium
avium subspecies paratuberculosis PCR was positive in one
case (sample 3). Samples were then also screened with
a seminested diagnostic PCR for avian mycobacteriosis.
However, unfortunately not of all samples enough material
was left, so this PCR could only be conducted with 20
samples as sample 9, and 18 was tested twice. Of these, 80%
tested positive in the seminested PCR. Sequencing of the4 Veterinary Medicine International
Table 2: Mean of hematology results of Gyr-Saker and Gyr-Peregrine hybrid falcons tested positive for A. baumannii and mycobacteriosis.
Parameters Gyr-Saker with




n = 2 n = 9
RBC (×1012/l) 2.15 2.18–2.48 2.02 2.13–2.65
Hb (g/dl) 12.60 16.23–19.23 12.23 16.33–19.47
Hct % 38.10 46.91–56.23 34.10 47.25–56.75
MCV (ﬂ) 166.45 200.29–243.49 186.62 194.32–245.08
MCH (pg) 58.40 69.41–83.07 67.48 67.14–84.04
MCHC (g/dl) 35.10 32.85–35.99 36.51 32.95–35.91
WBC (×109/l) 29.70 5.28–9.72 31.53 5.28–9.82
Heterophils% 71.00 46.02–53.78 72.90 46.41–53.41
Lymphocytes% 19.90 41.20–47.02 22.14 40.82–47.54
Monocytes% 3.00 2.84–6.00 3.31 2.77–6.03
Eosinophils% 1.00 0.37–2.21 1.26 0.29–2.45
Basophils% 0.50 0.25–0.55 0.56 0-0












n = 2 n = 9
GGT (U/L) 13.6 5.5–11.5 10.3 6.0–12.0
AST (U/L) 103.9 45.0–122.3 138.1 47.0–110.0
ALT (U/L) 122.8 37.2–91.0 116.6 44.9–73.5
TP (g/dl) 3.7 2.2–3.4 3.4 2.15–3.35
ALB (g/dl) 1.3 0.9–1.2 1.1 0.73–1.35
LDH (U/L) 2825.9 788.8–1493.3 2811.5 802.0–1457.0
CK (U/L) 466.9 312.3–681.3 740 341.0–668.7
UA (mg/ml) 5.9 3.4–7.5 9.5 3.60–7.0
UREA (mg/ml) 17.6 6.4–20.1 29.1 7.0–17.0
CHOL (mg/ml) 105.3 159.0–267.0 144.8 167.0–267.0
ALP (U/L) 227.8 — 169.2 —
AMYL (U/L) 159.5 — 857.6 —
amplicons revealed 100% sequence identity to the M. avium
complex (MOC) in all positive cases. Moreover, 60% were
positive in the speciﬁc A. baumannii PCR.
3.5. Therapeutic Results. Both falcons treated were adminis-
tered by a monotherapy of rifampicin 30mg/kg once a day.
Onefalconwastreatedfor68daysandrecovered.Subsequent
PCR tests for Mycobacterium sp. were negative. The other
falcon was treated for 45 days. It returned after 39 days in
apparently good condition and without visible granuloma-
tous lesions with intralesional mycobacteria, however, no
further PCR testing could be performed.
4. Discussion
Between May 2007 and April 2009, mycobacteriosis was
detected in 18 falcons. 16 of them tested positive in the
seminested mycobacteria PCR. Moreover, the 2 negative
samples tested positive for M. genus PCR. Furthermore, 2
samples were additionally tested positive for M. avium and
one for M. avium paratuberculosis. These ﬁndings stand in
sharp contrast to a study on pet birds where the causative
agents were mainly M. genavense a n do n l yi no n ec a s eM.
avium [14]Inthevastmajorityofcases(16falcons),thetime
frame of the examination of clinically healthy falcons untilVeterinary Medicine International 5
Table 4: Diagnostic results with Polymerase Chain reaction of positive cases in the second test run.








1+ + −− +
2+ + +
3 + + No sample + +
4+ + + −−
5+ + − +
6+ + −
7+ + + −−
8 + No sample −
9 − + − +
10 − + −
11 − ++
12 + − +
13 + + +
14 + + +
15 + − + −
16 + + +
17 + + +
18 + + +
clinical manifestation of mycobacteriosis ranged between 3
and 5 months. In two cases, falcons were diagnosed with
mycobacteriosis at the time of their ﬁrst presentation at the
Abu Dhabi Falcon Hospital. Therefore, the time of disease
manifestation is not known. One of these two falcons was
also tested positive for A. baumannii.
Cutaneous lesions of the diseased falcons were found
only as localized lesions on both body walls ranging from the
lower thoracical part to the abdominal areas as well as on the
inside of left and right thighs. The sizes were variable and
ranged from 0.5mm up to 5cm. The yellowish lesions were
of ﬁrm, leathery-like consistency. In contrast, in quails ﬁrm,
pale-colored nodes of diﬀerent sizes could be found from the
midcervical region up to the thoracic inlet [19].
Mycobacteriosis cannot be easily identiﬁed by hemato-
logicalchangesorclinicalsymptomsuntilthediseasereaches
more advanced stages [8]. In our study, the hematological
changes showed uniﬁed patterns with strong anemia, high
white blood cell counts, heterophilia and strong lympho-
cytopenia. Furthermore, basophilia was present. Further
hematological changes indicating a mycobacteriosis are
presence of low albumin and low total protein levels [20],
which however, could not be supported by the ﬁndings
of our study. In our study, albumin and total protein
levels were slightly elevated. On the other hand, changes in
hematologicalparametershavebeendescribedasnonspeciﬁc
[21]. In falcons, severe bacterial of fungal infections like
aspergillosis and pseudomoniasis can cause highly elevated
WBC and heterophilia associated with lymphocytopenia. As
in our study 39% of the falcons were not diagnosed with
any other disease than mycobacteriosis, the blood parameter
changes could not be caused by another underlying disease.
However, the hematological blood picture of the diseased
falcons in our study showed very distinctive change patterns,
thus, indicating a mycobacteriosis. In all performed acid-fast
bacilli stains, bacilli were clearly identiﬁed which is highly
indicative for a mycobacteriosis and got conﬁrmed through
the PCR results.
Ad i ﬃculty in avian mycobacteriosis identiﬁcation is the
fact that the bacterium gets mainly shed in the advanced
stages of the disease, but not in the early ones [22].
Unsuccessful identiﬁcation of mycobacterial species despite
repeated trials are reported in research [14]. This problem
might be related to severe DNA damage during processing
[23] which could be an explanation for the diﬃculties of
mycobacterium detection in our study. Another explana-
tion for unsuccessful mycobacterial detection might be the
extremely low quantity of mycobacterial DNA in paraﬃn-
embedded tissues [23]. Due to the unequal distribution of
mycobacteria in tissue samples, this reason might be also
applicable to the tissue samples in our study although only
fresh and not paraﬃn-embedded tissues were examined.
Treatmentofmycobacteriosiscantakeuptooneyearand
in successful cases included a combination of diﬀerent drugs
like clarithromycin, ethambutol, rifabutin, and enroﬂoxacin
[7]. Rifampicin is highly eﬃcient in combination with other
antimicrobials. It can be used as monotherapy although
during the treatment period limitations of its eﬃciency may
be caused through resistances [24]. In our case, rifampicin
was used as monotherapy for 45 and 68 days leading to6 Veterinary Medicine International
the survival of the two only falcons treated. One of them
was tested negative repeatedly. Moreover, its skin lesion
disappeared completely after gradual regression. At the time
oftreatment,thediagnosisofA.baumanniiinfectionwasnot
yet established.
The ﬁnding of the presence of A. baumannii was com-
pletely unexpected. So far, as to the authors’ knowledge, no
cutaneous mycobacteriosis lesions in animals and birds have
beenfoundinassociationwithA.baumanniiso far. However,
A. baumannii infections cannot only be observed in humans,
but also in animals like cats, dogs [25], and horses [26].
Random sampling of a zoological collection in Japan led to
the isolation of Acinetobacter baumannii from the feces of
wildbirds.However,itwasnotmentionedifanypathological
condition of the birds was present [27]. Commercially
available microbiology testing systems like Mini-API or
Vitek are not successful in the detection of A. baumannii
but its identiﬁcation by ITS sequencing is regarded as a
very reliable method [17]. A 2.6kbp DNA fragment was
identiﬁed from a multidrug-resistant A. baumannii strain
in a horse. This cassette structure was identical to that
isolated in an unrelated human Acinetobacter strain. As the
numbers of isolates in humans carrying the class 1 integrons
are on the rise, this might be applicable to animals as
well. Therefore, the transmission from human-to-animal or
animal-to-human of MDR Acinetobacter spp. seems to be
possible [28].
In the regular monthly facility screening of the Abu
Dhabi Falcon Hospital, A. baumannii was never detected
throughout the years 2006, 2007, and 2008—except in
December 2007. In the facility screening of December 29th
2007, A. baumannii was identiﬁed on the exam room work
table, adjacent work bench and computer as well as one
glove used for holding falcons. This clearly indicates that
this pathogen was not present in the hospital 17 month
before the diseased falcons were diagnosed. Moreover, after
immediate cleaning up of the aﬀected areas, A. baumannii
was not detected again until August 2008. Due to the fact
that one falcon of this study was presented in the Abu
Dhabi Falcon Hospital for examination on December 27th,
2007, these ﬁndings strongly indicate that the infected falcon
had shed the bacteria when arriving at the hospital. The
contamination camethereforepresumablythrough handling
of this falcon. Moreover, in one falcon that was presented
for the ﬁrst time at the Abu Dhabi Falcon Hospital, A.
baumannii was isolated from a cutaneous lesion. This leads
to the assumption that a nosocomial infection of the falcons
in our study does not seem likely although nosocomial
A. baumannii infections are frequently found in hospitals
[4]. The route of transmission of mycobacteriosis and A.
baumannii in the falcons of this study remains unclear due
to the fact that they come from diﬀerent breeders, owners
and are kept in diﬀerent places.
It seems likely that the falcons became infected with
A. baumannii through contaminated wild birds, possibly
through their feces [27], which they might have caught while
hunting. However, it remains unclear to what extent wild
birds are infected with A. baumannii and what might be the
likelihood of a possible interspecies transmission. Further
research is needed in this subject. Moreover, the ﬁndings of
this study raise the question if a human-to-birds or birds-to-
human transmission of A. baumannii exists which requires
further investigation.
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